These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7474556)

  • 41. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
    J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
    [TBL] [Abstract][Full Text] [Related]  

  • 42.
    Li L; Zhou YF; Li YL; Wang LL; Arai H; Xu Y
    World J Gastroenterol; 2017 Apr; 23(16):2912-2927. PubMed ID: 28522909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.
    Schiess W; Dorow P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S30-3. PubMed ID: 2439815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between plasma concentrations and cardiac beta-adrenoceptor blockade--a study with oral and intravenous bopindolol.
    Aellig WH; Nüesch E; Engel G; Grevel J; Niederberger W; Rosenthaler J
    Br J Clin Pharmacol; 1986 Jan; 21(1):45-51. PubMed ID: 2868747
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
    Shulkin BL; Peele ME; Utiger RD
    Endocrinology; 1984 Sep; 115(3):858-61. PubMed ID: 6146516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
    Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myocardial anti-ischemic characteristics of a novel class of beta-adrenoceptor blockers.
    Mousa SA; Patil G; Mayo MC; Tong TM
    Int J Clin Pharmacol Ther Toxicol; 1992 Mar; 30(3):103-6. PubMed ID: 1354656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney.
    Kakoki M; Hirata Y; Hayakawa H; Nishimatsu H; Suzuki Y; Nagata D; Suzuki E; Kikuchi K; Nagano T; Omata M
    Hypertension; 1999 Jan; 33(1 Pt 2):467-71. PubMed ID: 9931149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protection by beta-blocking agents against free radical-mediated sarcolemmal lipid peroxidation.
    Mak IT; Weglicki WB
    Circ Res; 1988 Jul; 63(1):262-6. PubMed ID: 2898307
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of beta blocking drugs on lipid peroxidation in rat heart in vitro.
    Jenkins RR; Del Signore CM; Sauer P; Skelly C
    Lipids; 1992 Jul; 27(7):539-42. PubMed ID: 1360612
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanism of renin inhibition by beta adrenergic blocking agents. Effects of dl-, d-, l-propranolol and pindolol on renin release.
    Saruta T; Eguchi T; Nakamura R; Misumi J; Kondo K; Oka M
    Jpn Heart J; 1980 Jan; 21(1):103-9. PubMed ID: 6102616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Membrane stabilizing activity and beta-adrenoceptor antagonist-induced bradycardia in conscious dogs.
    Boucher M; Chapuy E; Duchêne-Marullaz P
    Eur J Pharmacol; 1992 Feb; 211(3):343-9. PubMed ID: 1352254
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bopindolol in chronic stable angina pectoris: duration and extent of antianginal action.
    Carboni GP; Scardovi AB; D'Ermo M; Prati PL
    Br J Clin Pharmacol; 1991 Dec; 32(6):755-7. PubMed ID: 1685090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bopindolol: Czechoslovak experience with a new beta blocker in the treatment of hypertension.
    Widimský J; Lefflerová K; Dvorák I; Fedelesová V; Lupínek Z; Mayer O; Pinterová E
    Am J Cardiol; 1991 Apr; 67(10):36B-42B. PubMed ID: 1673580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of propranolol-resistant (-)-[125I]-cyanopindolol binding sites in rat soleus muscle.
    Roberts SJ; Molenaar P; Summers RJ
    Br J Pharmacol; 1993 Jun; 109(2):344-52. PubMed ID: 8102926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The affinity of bopindolol and its two metabolites for a beta 2-adrenoceptor in the bovine mesenteric artery.
    Hosohata Y; Suzuki M; Karakisawa Y; Maruyama K; Nagatomo T
    Biol Pharm Bull; 1994 Sep; 17(9):1296-8. PubMed ID: 7841957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanism of antioxidant action of pueraria glycoside (PG)-1 (an isoflavonoid) and mangiferin (a xanthonoid).
    Sato T; Kawamoto A; Tamura A; Tatsumi Y; Fujii T
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):721-4. PubMed ID: 1611684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bopindolol: a new long acting beta-receptor antagonist; its effects on haemodynamics, and on the renin response to tilting.
    Turner DR; Goodwin FJ; Knight AR; Littlejohns DW; Sharman VL; Vere DW
    Br J Clin Pharmacol; 1984 Mar; 17(3):295-9. PubMed ID: 6143566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol.
    Van den Branden C; Gabriels M; Vamecq J; Vanden Houte K; Verbeelen D
    Nephron; 1997; 77(3):319-24. PubMed ID: 9375827
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Haemodynamic effects of atenolol and bopindolol at rest and during isometric exercise. A non-invasive study in healthy volunteers.
    Nieminen MS; Rapola J; Pellinen TJ; Toivonen L
    Ann Clin Res; 1988; 20(6):431-5. PubMed ID: 2905879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.